Clinical Trials Insight: 700040556

Trial Profile

Clinical Trials Insight: 700040556

Phase of Trial: Phase II

Latest Information Update: 16 Jan 2009

At a glance

  • Drugs Irinotecan (Primary)
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Sponsors Nektar Therapeutics
  • Most Recent Events

    • 16 Jan 2009 New trial record.
    • 13 Jan 2009 Institutional Review Board approval received, according to a Nektar Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top